View Author
patient study cancer model group treatment analysis method table variable score result value factor disease survival signi probability tumor scale performance dysphagia month number discriminant oncol therapy melanoma lymph outcome regression discriminant analysis methods surgery breast structure ficant measure muscle sample chemotherapy disability discriminant analysis radiotherapy questionnaire discrimination prognostic function stroke trial rotterdam procedure netherland schmitz difference radiation situation relationship follow-up incision grade control signi ficantly trastuzumab center dissection vibration parameter problem multivariate response epilepsy interaction range population recurrence reconstruction sentinel eortc likelihood children
10 Most Recent Publications
|
Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence?
(Article)
Oosten, A.W. Oldenmenger, W.H. Zuylen, C. van Schmitz, P.I.M. Bannink, M. Lieverse, P.J. Bromberg, J.E.C. Rijt, C.C.D. van der |
2011-10-01
|
|
Therapeutic Surgical Management of Palpable Melanoma Groin Metastases: Superficial or Combined Superficial and Deep Groin Lymph Node Dissection
(Article)
Ploeg, A.P.T. van der Akkooi, A.C.J. van Schmitz, P.I.M. Geel, A.N. van Wilt, J.H.W. de Eggermont, A.M.M. Verhoef, C. |
2011-05-03
|
|
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: Hertax trial
(Article)
Hamberg, P. Bos, M.M.E.M. Pruijt, J.F.M. Loosveld, O.J.L. Smit, W.M. Muller, E.W. Schmitz, P.I.M. Seynaeve, C.M. Klijn, J.G.M. Braun, H.J.J. Stouthard, J.M.L. Deijk, G.A. van Erdkamp, F.L.G. Stelt-Frissen, I.N. van der Bontenbal, M. Creemers, G.J.M. Portielje, J.E.A. |
2011-04-01
|
|
Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time
(Article)
Graaf, M.T. de Broek, P.D.M. van den Kraan, J. Luitwieler, R.L. Bent, M.J. van den Boonstra, J.G. Schmitz, P.I.M. Gratama, J-W. Sillevis Smitt, P.A.E. |
2011-03-12
|
|
Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: Analysis of prognostic factors
(Article)
Geel, A.N. van Wouters, M.W.J.M. Lans, T. Schmitz, P.I.M. Verhoef, C. |
2011-01-01
|
|
EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria
(Article)
Ploeg, A.P.T. van der Akkooi, A.C.J. van Schmitz, P.I.M. Koljenovic, S. Verhoef, C. Eggermont, A.M.M. |
2010-09-01
|
|
Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel
(Article)
Strijbos, M.H. Gratama, J-W. Schmitz, P.I.M. Rao, C. Onstenk, W. Doyle, G.V. Miller, M.C. Wit, R. de Terstappen, L.W.M.M. Sleijfer, S. |
2010-07-01
|
|
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
(Article)
Surmont, V. Aerts, J.G.J.V. Klaveren, R.J. van Tournoy, K. Tan, K.Y. Vernhout, R. Schmitz, P.I.M. Legrand, C. Hoogsteden, H.C. Meerbeeck, J.P. van |
2010-06-01
|
|
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study
(Article)
Surmont, V. Aerts, J.G.J.V. Klaveren, R.J. van Pouw, E. Tan, K.Y. Vernhout, R. Gras, J. Salomé, J. Pronk, T. Schmitz, P.I.M. Hoogsteden, H.C. |
2009-12-01
|
|
Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence
(Article)
Pol, C. van der Geel, A.N. van Menke-Pluymers, M.B.E. Schmitz, P.I.M. Lans, T. |
2009-12-01
|
